ArticleScientific reports2026
Feasibility of transumbilical and prior caesarean scar access in single-incision laparoscopic common bile duct exploration for extrahepatic bile duct stones.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Open common bile duct exploration (CBDE) for extrahepatic stones results in prominent abdominal scarring and substantial tissue trauma. Laparoscopic exploration offers minimal invasiveness and faster recovery and has proven superior to staged procedures; however, single-incision laparoscopic exploration remains inadequately studied. We retrospectively analysed data from 18 patients who underwent single-incision laparoscopic common bile duct exploration (SIL-CBDE) for extrahepatic bile duct stones between March 2022 and June 2024 in the Department of General Surgery at the 901st Hospital of the Joint Logistics Support Force. Demographic characteristics, surgical details, and outcomes were documented. Among the 18 patients, 7 were male and 11 were female, with a mean age of 47.72 ± 14.82 years. Surgical approaches included transumbilical (n = 14) and transabdominal via previous caesarean scars (n = 4). SIL-CBDE was successfully completed in 17 patients (94.4%), while one patient (5.6%) required conversion to three-port laparoscopy. No residual stones were found postoperatively, with an operation time of 160 (131.25, 185.00) minutes and a hospital stay of 5.50 (4.75, 7.00) days. An abdominal drain was placed in 11 patients (61.1%), while 7 (38.9%) did not receive prophylactic drainage. One patient (5.6%) experienced bile leakage after surgery, which was cured after abdominal drainage. All patients were monitored until October 2024, during which time there was no recurrence of stones, bile duct stricture, readmission, or fatality. SIL-CBDE appears to be a safe and feasible procedure. Furthermore, utilizing a previous caesarean section scar for access represents a novel application and may provide a valuable alternative for a specific subset of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.